A principal objective of spinal cord injury (SCI) research is the restoration of axonal connectivity to denervated targets. We tested the hypothesis that chemotropic mechanisms would guide regenerating spinal cord axons to appropriate brainstem targets. We subjected rats to cervical level 1 (C1) lesions and combinatorial treatments to elicit axonal bridging into and beyond lesion sites. Lentiviral vectors expressing neurotrophin-3 (NT-3) were then injected into an appropriate brainstem target, the nucleus gracilis, and an inappropriate target, the reticular formation. NT-3 expression in the correct target led to reinnervation of the nucleus gracilis in a dose-related fashion, whereas NT-3 expression in the reticular formation led to mistargeting of regenerating axons. Axons regenerating into the nucleus gracilis formed axodendritic synapses containing rounded vesicles, reflective of pre-injury synaptic architecture. Thus, we report for the first time, to the best of our knowledge, the reinnervation of brainstem targets after SCI and an essential role for chemotropic axon guidance in target selection.
Functional deficits after SCI are primarily caused by the destruction of axonal connections between neurons and failure of spontaneous axonal regeneration. Regeneration failure is attributed to factors intrinsic to injured neurons, including the inability to activate genetic growth programs [1] [2] [3] [4] , and to extrinsic factors, including molecular inhibitors 5 . By systematically targeting these mechanisms, a number of experimental strategies promote either sprouting of spared axons or regeneration of injured axons in and beyond sites of SCI [6] [7] [8] [9] [10] [11] .
An unfulfilled goal of spinal cord regeneration research remains the reinnervation of natural neuronal targets. Target reinnervation has become a more prescient issue as individual and combined strategies for eliciting axonal regeneration succeed in promoting axonal growth beyond lesion sites. Once a regenerating axon emerges from a site of injury and encounters potential distal neuronal targets for reinnervation, will the axon locate an appropriate target among millions of potentially incorrect neuronal partners? Can guidance signals used during development, such as neurotrophic factors, also guide adult regenerating axons? Once axons reach a target, will they form synapses, will they do so at appropriate sites on postsynaptic neurons and will they show appropriate excitatory versus inhibitory synaptic morphologies?
Recent progress in promoting bridging growth of dorsal column sensory axons after adult SCI provides an opportunity to test the hypothesis that developmentally regulated guidance mechanisms will direct regenerating axons to appropriate targets and support new synapse formation in the adult CNS and, more specifically, in a natural brainstem target. We recently reported that the combination of a cellular matrix placed in a lesion cavity, a conditioning stimulus to the neuronal cell body and growth factor gradients beyond a lesion succeed in promoting sensory axon regeneration into and beyond a C4 spinal cord lesion site 8, 10 . Under these circumstances, axons regenerate distances of several millimeters, but remain 10 mm short of their natural target in the brainstem, the nucleus gracilis. To study mechanisms that direct axonal growth into targets, we placed spinal cord lesions at C1, an approximate 2-mm distance from the nucleus gracilis, establishing a situation in which axons emerging from the graft encounter several gray matter neuronal groups as 'choices' for growth in the caudal medulla (Fig. 1) . These neuronal groups included the nucleus gracilis, an appropriate target, and the underlying medullary reticular formation, an inappropriate target. We then examined whether NT-3 would guide regenerating sensory axons to their appropriate target and support synapse formation.
We found that regenerating axons in the injured adult CNS used chemotropic mechanisms to direct growth beyond a lesion site and into an appropriate target. Furthermore, axons regenerating into their natural adult target re-established appropriate axo-dendritic synapses with the host and adopted pre-injured patterns of asymmetric, excitatory synapses. Thus, regeneration into natural targets was experimentally induced after adult SCI.
RESULTS
Previous ELISA measurements established that injections of lentiviral vectors expressing NT-3 constitute a gradient of NT-3 protein that peaks at the site of vector injection and progressively diminishes to undetectable levels 4 mm from the injection site 10 . We therefore used lentiviral vectors to topographically express NT-3 in the brainstem to determine whether NT-3 could guide regenerating axons into specific targets beyond the lesion. Rats underwent dorsal column lesions at C1 followed by grafting of autologous bone marrow stromal cells (MSCs) into the lesion site to provide a cellular 'bridge' for regenerating axons 8, 10, 12 (Fig. 1) . Fluorogold, a tracer that undergoes retrograde transport, was injected into the thalamic ventroposterolateral nucleus, where axons projecting from the nucleus gracilis terminate, allowing identification of individual neuronal targets in the nucleus gracilis. After lesions and cell grafting, we injected the rats with lentiviral vectors expressing either NT-3 or green fluorescent protein (GFP, control) into the nucleus gracilis and the medullary reticular formation, providing two potential target sites for regenerating axons beyond the lesion. We employed sciatic nerve preconditioning lesions, which have been shown to promote axonal regeneration of ascending sensory axons 8, [13] [14] [15] [16] , in combination with NT-3 delivery to elicit axon growth beyond the C1 lesion toward sites of NT-3 expression. Axonal regeneration was assessed on the basis of cholera toxin B subunit (CTB) transganglionic labeling of injured dorsal column sensory axons 1 month after lesion or treatment.
Seven rats received conditioning lesions and injections of NT-3 lentiviral vectors (titer 100 mg ml À1 p24 protein) into the nucleus gracilis and the medullary reticular formation (Lenti-NT-3+CL). Six rats received the same Lenti-NT-3 injections, but no conditioning lesion (Lenti-NT-3+NoCL). Eight rats received conditioning lesions and injections of GFP lentiviral vectors into the gracile and reticular nuclei (Lenti-GFP+CL) and NT-3 was not provided. Finally, nine rats received Lenti-GFP injections into both brainstem nuclei and no conditioning lesion (Lenti-GFP+NoCL).
After obtaining preliminary results from the groups above, we added an additional group of full treatment subjects (conditioning lesions and Lenti-NT-3 injection) (Lenti-NT-3 high+CL, seven rats). In these rats, Lenti-NT-3 vector was injected solely into the nucleus gracilis at a twofold higher vector titer (200 mg ml À1 p24) to determine whether increased NT-3 expression in the nucleus gracilis would correspondingly increase sensory axonal regeneration into the appropriate target. Before analysis of axon regeneration, we assessed lesion completeness in all of the groups using conservative criteria (see Online Methods). To allow for comparison between the intact nucleus gracilis and the nucleus gracilis after injury, we gave five rats CTB tracer injections and no C1 lesion.
Combined treatment promotes nucleus gracilis reinnervation
Immunohistochemistry for NT-3 showed NT-3 expression in the nucleus gracilis only in rats that received Lenti-NT-3 vectors (Supplementary Fig. 1 ). Rats that received NT-3 delivery to the brainstem showed sensory axon regeneration beyond the lesion site, whereas those that received GFP delivery did not (Figs. 2 and 3) . Moreover, in the presence of Lenti-NT-3 targeting to the nucleus gracilis, axons regenerated into this appropriate target (Fig. 2) . Comparing the number of axon profiles in the nucleus gracilis between groups that received equivalent titers of lentiviral vectors, only the full combinatorial treatment (Lenti-NT-3+CL) significantly promoted greater axon growth into the target compared with controls (P o 0.01; Figs. 3 and 4) . Figure 1 Experimental procedure. Nucleus gracilis neurons were retrogradely labeled using bilateral injection of Fluorogold (FG, orange) into the ventropostero-lateral (VPL) thalamus 1 week before dorsal column lesions (1) . Some rats received bilateral sciatic nerve conditioning lesions, whereas controls received no sciatic nerve lesions (2) . We used a wire knife to transect the dorsal columns approximately 1.5 mm caudal to the obex 7 d later and grafted MSCs into the lesion site (3). Immediately after grafting, lentiviral vectors expressing both NT-3 and GFP (Lenti-NT-3, GFP is expressed from an internal ribosome entry site in the same construct) or GFP alone (Lenti-GFP) were injected into the nucleus gracilis and median reticular nucleus bilaterally, slightly rostral and lateral to the obex, or to the nucleus gracilis alone (4) . Ascending sensory tracts were bilaterally labeled using CTB injections into the sciatic nerve4 weeks later; 3 d after CTB injections, rats were killed by perfusion. Subjects receiving cell grafts and Lenti-NT-3 injections into the nucleus gracilis without conditioning lesions (Lenti-NT-3+NoCL) had twofold fewer axonal profiles in the nucleus gracilis than combinatorially treated rats and did not significantly differ from controls (P 4 0.05; Figs. 3 and 4). Furthermore, only half of the rats in the Lenti-NT-3+NoCL group had bridging axons, whereas all of the rats in the Lenti-NT-3+CL group had bridging axons. Among control groups treated only with cell grafts and Lenti-GFP injections (Lenti-GFP+NoCL), axons did not extend beyond the lesion site or into the nucleus gracilis. In control rats receiving Lenti-GFP injections, cell grafts and conditioning lesions (Lenti-GFP+CL), only rare axons extended to the rostral host-graft interface and none entered the nucleus gracilis (Figs. 3 and 4) . After establishing that full combinatorial treatment achieved significant regenerative axon growth into the target nucleus, we examined whether increasing NT-3 expression exclusively in the nucleus gracilis could further augment axon growth in combinatorially treated rats. In fact, rats that received full combinatorial treatment with high-titer Lenti-NT-3 vectors targeted solely to the nucleus gracilis (Lenti-NT-3 high+CL) had significantly higher axon numbers in the target compared with rats that received combinatorial treatment with low-titer NT-3 vectors (Lenti-NT-3+CL, P o 0.05; Figs. 3 and 4) . Examination of reporter gene expression (Lenti-NT-3 constructs express GFP via an internal ribosome entry site) confirmed that vector spread in the target significantly increased on administration of the higher vector dose (P o 0.05; Fig. 4) . Thus, axons exhibited a dose-dependency to growth in the target.
To estimate the extent of axonal regrowth in lesioned and treated groups, we compared the number of axon profiles in the nucleus gracilis with that intact rats (Figs. 3 and 4) . Lenti-NT-3 high+CL treatment restored the number of axon profiles to 27% of that observed in the intact nucleus gracilis. Lenti-NT-3+CL restored 6.8% of axonal profiles and Lenti-NT-3+NoCL restored only 3%. Thus, conditioning lesions together with chemotropic guidance achieved a relatively high degree of target re-penetration by regenerating axons.
NT-3 guides axons to appropriate brainstem targets Rats with NT-3 expression in the correct target, the nucleus gracilis, had axonal growth throughout the nucleus. Regions of axonal growth precisely Figure 3 Comparison of axon growth into the nucleus gracilis after viral GFP or NT-3 delivery with or without conditioning lesions. (a-f) Axons were observed to regenerate beyond the rostral lesion border (arrows) and into the nucleus gracilis (dashed lines) in rats that received hightiter NT-3 virus delivered to the nucleus gracilis and conditioning lesions (Lenti-NT-3 high+CL group, a,b), standard-titer NT-3 virus delivered to the gracile and reticular nuclei and conditioning lesions (Lenti-NT-3+CL group, c,d) and standardtiter NT-3 virus delivered to the gracile and reticular nuclei without conditioning lesions (Lenti-NT-3+NoCl group, e,f). The greatest number of axons was observed in rats with combinatorial treatment (a-d), and among these two groups, more axons were observed when hightiter NT-3 virus was delivered to the nucleus gracilis (a,b) (see Fig. 4 ). (g,h) In contrast, no axons were observed in the nucleus gracilis in rats that received GFP lentivirus delivery and conditioning lesions (Lenti-GFP+CL group) or GFP lentivirus alone (Lenti-GFP+NoCL, data not shown). correlated with the topography of Lenti-NT-3-GFP reporter gene expression in the target (Fig. 2) . Rats that were subjected to NT-3 expression in the incorrect target, the medullary reticular formation, demonstrated axon growth in these ectopic regions of NT-3 expression (Fig. 5) .
In one case, Lenti-NT-3 was mistargeted 900 mm rostral to the nucleus gracilis in the brainstem; in this rat, axons grew beyond the nucleus gracilis along the mistargeted zone of Lenti-NT-3 expression. In contrast, we did not observe ectopic axons in intact rats or among subjects in which Lenti-NT-3 was expressed only in the nucleus gracilis. Thus, NT-3 specifically guided regenerating adult axons toward targets. These results demonstrate that axons regenerating after adult CNS injury have classic directional and dose responsiveness to chemotropic gradients of growth factors.
Regenerating sensory axons form synapses in the target
Confocal analysis demonstrated that regenerated CTB-labeled axons in the nucleus gracilis intimately associated with Fluorogold-labeled target neurons (Fig. 6a,b) . To determine whether adult, injured axons re-formed synapses on reaching their gracilar target, we analyzed the nucleus gracilis by immuno-electron microscopy in two rats receiving combinatorial treatment and high-titer Lenti-NT-3 delivery specifically to the nucleus gracilis (Lenti-NT-3 high+CL) and in three intact rats. We screened 2-5 ultrathin sections from the nucleus gracilis per rat for evidence of CTB-labeled axon terminals at 4,800Â magnification. Regenerating axon terminals were identified ultrastructurally by their electron-dense appearance, after immunohistochemical labeling for CTB and processing for streptavidin-horseradish peroxidase (HRP) reaction product ( Fig. 6c-e) .
We identified a total of six CTB-labeled axon terminals ultrastructurally in two lesioned/combinatorially treated rats (two in one rat and four in another) and ten terminals in three intact rats. Each CTBlabeled axon terminal in lesioned/combinatorially treated rats contained specializations with ultrastructural features of synapses (Fig. 6c,d) . Regenerated terminals showed formation of asymmetric synaptic specializations with a prominent postsynaptic element, typical of excitatory synapses 17, 18 . Dense clusters of synaptic vesicles were evident in these terminal regions, indicating the formation of functional structures required for neurotransmitter storage and release. Boutons in regenerated CTB-labeled axon terminals contained round rather than flattened synaptic vesicles, further suggesting an excitatory neurotransmitter phenotype 19 . Four of the six regenerating axon terminals studied made synaptic contacts with multiple dendritic targets, a feature that is common for primary afferent projections to the gracile nucleus in intact rats 20, 21 (see below); the remaining two terminals made synaptic contact with single dendritic targets. Finally, CTB-containing regenerating axon terminals made synaptic contacts with dendritic rather than somal elements, a feature that is typical of the pre-injury ultrastructural phenotype [20] [21] [22] . As with terminals in lesioned/combinatorially treated rats, synaptic boutons in intact subjects contained many round synaptic vesicles, made synaptic contacts with single or multiple dendritic targets, and had asymmetric synaptic specializations (Fig. 6e) .
Here, we did not formally quantify CTB-labeled boutons. However, in equal proportions of tissues scanned ultrastructurally, we detected labeled synapses approximately 30% as frequently in lesioned/combinatorially treated rats as in intact rats. That is, we identified six synapses in approximately 80 fields examined in lesioned/combinatorially treated subjects and ten synapses in approximately 40 fields in intact subjects. Thus, synapse formation in regenerated subjects occurred regularly and was not a rare event.
Electrophysiological studies
To assess whether synaptic activity could be observed in association with regenerated axons, we recorded extracellularly from the nucleus gracilis in lesioned/combinatorially treated rats 6 weeks after treatment.
To establish a procedure for recording postsynaptic potentials from the nucleus gracilis, we sampled 20-50 sites throughout the nucleus gracilis in intact rats for activity following electrical stimulation of the sciatic nerve (Fig. 7a,b) . Evoked responses were readily detected in three intact rats and in three rats without C1 lesions that received conditioning lesions 6 weeks before recording. The number of sites in which responses could be evoked and the overall magnitude of the evoked responses comparing intact and sciatic nerve-conditioned rats (Fig. 7c) indicated that conditioning lesions did not affect the ability to elicit an evoked response. Local application of the glutamate antagonist kynurenic acid nearly abolished evoked responses and responses returned to near baseline levels after washout of kynurenic acid, indicating that responses were synaptically mediated. (Fig. 7a,b) . In addition, in intact rats, subsequent transection of the dorsal columns at thoracic level 3 (T3) completely abolished evoked responses in the nucleus gracilis, indicating that recorded potentials were transmitted through the dorsal columns (Fig. 7a,b) . In C1-injured rats, detection of afferent volleys just caudal to the C1 lesion indicated that the intact portions of ascending sensory axons transmitted responses to sciatic nerve stimulation up to the level of the lesion. Next, we compared responses in intact rats to responses in C1-injured rats that underwent treatment with cell grafts, conditioning lesions and high-titer NT-3 (Lenti-NT-3 high+CL, n ¼ 5) or GFP vector injections (Lenti-GFP high+CL, n ¼ 3) into the nucleus gracilis (Fig. 7c) . Because histological analysis showed that GFP vector delivery did not support axonal growth into the nucleus gracilis, we used the maximum root mean square (RMS) response recorded in the Lenti-GFP control group as a threshold for analyzing responses in intact and NT-3-treated rats to determine whether responses at individual recording sites exceeded the background response. Postsynaptic potentials in intact rats exceeded the threshold response at 67% of recording sites that we sampled. In contrast, among rats treated with Lenti-NT-3 high+CL, only two responses, representing 1.4% of recording sites, exceeded those of GFP-expressing control rats. Response curves associated with these two sites did not differ qualitatively from those of GFP control rats, nor did they resemble postsynaptic potentials observed in intact rats (Fig. 7d) . Thus, combinatorial interventions did not result in detectable postsynaptic potentials in the target in the regions that we sampled.
Given the fact that combinatorial treatment restored the number of axonal profiles in the nucleus gracilis to 27% of intact values and that ultrastructural analysis readily revealed synapses in the target tissue, we explored whether factors besides limited sampling of the nucleus gracilis might account for the absence of detectable synaptic activity. In particular, previous studies indicate that demyelinated dorsal column axons fail to sustain efficient conductivity 23, 24 . Using double labeling for myelin-associated glycoprotein (MAG) and the dorsal column tracer CTB, we confirmed that ascending dorsal column sensory axons projecting toward the lesion site retain myelin sheaths (Fig. 7e) . However, CTB-labeled axons regenerating into and beyond the lesion site remained demyelinated or sparsely myelinated (Fig. 7f,g ). These findings provide a potential mechanism that accounts for the lack of detectable synaptic activity in combinatorially treated 
Lesion completeness
Criteria to assess lesion completeness included the disruption of glial fibrillary acidic protein (GFAP) labeling at all dorsoventral levels through the graft/lesion site, distinct tissue architecture indicative of cell graft throughout the graft/lesion site under phase contrast optics and lack of bridges of spared tissue in the lesion in all serial sagittal sections examined by GFAP and phase contrast analysis. Using these criteria, we excluded three rats from the Lenti-NT-3+ NoCL group and one rat from the Lenti-NT-3+CL group; these rats were not included in the stated numbers per group. Although we did not observe clearly spared axons in these rats, we could not confirm a complete absence of bridging GFAP-immunoreactive tissue in these subjects, and to employ the most conservative criteria, eliminated the rats from further consideration.
DISCUSSION
The mechanisms that underlie axon growth and directional guidance during neural development have been extensively studied, yielding evidence that chemotropic gradients of growth factors are important in axonal target finding, dendritic growth and terminal synapse formation [25] [26] [27] [28] [29] . Studies that examine mechanisms underlying axon growth and potential target-finding after injury in the adult spinal cord have, by necessity, been far more limited, as until recently there was only limited success in promoting axonal regeneration beyond lesion sites. Taking advantage of combinatorial strategies for promoting bridging regeneration beyond lesion sites 8, 9, 30 and the ability to control local concentrations and topographies of administered growth factors in vivo in adult rats, we have identified distinct chemotropic mechanisms underlying axonal regeneration in the injured adult spinal cord. Using methods that achieve chemotropic gradients of growth factors in appropriate and inappropriate targets in vivo, we report for the first time, to the best of our knowledge, the reinnervation of a normal target, the nucleus gracilis, by lesioned, regenerating spinal cord axons and the chemotropic dependence of this regeneration.
During neural development, regional patterns of neurotrophin expression exert control over axonal guidance and termination in various regions of the nervous system [31] [32] [33] , including visual cortex 26, 27, 34 , the peripheral nervous system 35, 36 , central projections of sensory systems 29 and the vestibular system 37 . Here, we expressed NT-3 in both an appropriate target and an inappropriate target for regenerating axons and found that axons extended in a topographical distribution that precisely matched regions of NT-3 expression. Indeed, axons could be drawn to inappropriate regions on the basis of ectopic NT-3 expression, even bypassing a correct target to grow into an NT-3 source. In the absence of NT-3 expression, axons did not reinnervate the target nucleus. In contrast, increasing NT-3 expression in the target (by increasing NT-3 vector dose) significantly increased regeneration into the appropriate region (P o 0.05). Collectively, these findings indicate that NT-3 guided regenerating axons to specific topographies and that an absence of NT-3 resulted in elimination of regenerating axons. Thus, chemotropic guidance mechanisms observed during neural development may be critical in supporting target reinnervation by regenerating axons in adulthood.
This study is, to the best of our knowledge, the first to demonstrate reinnervation of a natural brainstem target by regenerating spinal cord axons. Although previous studies in models of axonal injury in the brain have demonstrated target reinnervation in the visual system 38 , hippocampus 39 and nigrostriatal projection 40 , mechanisms guiding target reinnervation, including chemotropic gradients established by growth factors, have not previously been addressed. In previous studies, lesions were either placed in the appropriate target (for example, striatum) or bridges for regenerating axons ended in an appropriate target (for example, direct placement of a sciatic nerve bridge in the lateral geniculate 41 ), thereby providing unitary targets rather than a choice between appropriate or inappropriate targets for regenerating axons. In some disease models, and SCI in particular, innumerable incorrect targets become available to regenerating axons, and guidance of regenerating axons is therefore of paramount importance. Here, we found that axons can be guided to appropriate targets using chemotropic gradients of growth factors expressed in correct regions.
Furthermore, we found that axons regenerating into the target form synapses. These synapses had appropriate excitatory features of the preinjured projection, including asymmetric synaptic specializations and clear, rounded vesicles. Axo-dendritic, rather than axo-somatic, synapses and the presence of multiple synaptic targets arising from single axonal terminal shafts are features that are consistent with the pre-injured ultrastructural phenotype of the dorsal column nuclei 20 . Thus, using ultrastructural criteria, the regenerating axon terminals closely resembled the corresponding synaptic boutons in intact rats.
Although axons formed synapses when regenerating into the nucleus gracilis, we did not determine whether axons regenerating into an ectopic target, the reticular formation, also formed synapses. Studies in other systems have indicated that axons sprouting into ectopic locations modify functional outcomes, suggesting that they probably form synapses in these regions (for example, see refs. [42] [43] [44] . For example, chronic constrictive lesions of the sciatic nerve cause spontaneous and ectopic growth of sympathetic axons into dorsal root ganglia, which is associated with dysesthetic pain that can be prevented by blockade of ectopic axon growth 42 . Thus, axons growing into either appropriate (present study) or ectopic 42 targets are probably capable of forming synapses.
An important consideration in any study reporting axonal regeneration is the possibility that spared axons may be mistaken for regenerating axons 45 . Several observations suggest that the regenerating axons that we observed in our lesioned rats were not spared. First, we employed conservative criteria to eliminate subjects in which the extent of the lesion was uncertain, based on observations of two experienced, blinded observers. Furthermore, we observed axons emerging from all levels of the rostral host/graft interface, rather than simply at the most dorsal or ventral parts, where spared axons might be expected. In addition, we observed axons in ectopic locations beyond the lesion site, where axons are not found in intact rats. In all cases, axons beyond the lesion grew only in regions of NT-3 expression, a finding that would not be expected had axons been spared. Finally, we did not observe axons in the target region in any rats that received control (GFP) lentiviral vector injections. Together, these observations support the presence of regenerated rather than spared axons in the nucleus gracilis.
Although lesioned axons in combinatorially treated rats could be directed into the target and formed synapses, we did not detect electrophysiological responses in the nucleus gracilis following sciatic nerve stimulation. Because we sampled a relatively small volume of the total structure, the absence of target responsiveness may have resulted from limited sampling. However, intact rats had electrophysiological responses in 67% of the sampled sites and NT-3 high+CL treatment restored the number of axonal profiles in lesioned rats to 27% of those in intact rats. Thus, if reinnervating axons formed fully functional synapses, one would predict that we would have detected electrophysiological responses in approximately 18% of the sampled sites (67% of 27%) in combinatorially treated rats.
Alternatively, lack of detectable activity might occur if the majority of regenerating axons failed to form synapses; however, synapses associated with CTB-labeled boutons were readily identifiable at the ultrastructural level in both intact and lesioned/combinatorially treated rats. Furthermore, synapses in regenerating rats had ultrastructural features of normal synapses, including abundant rounded synaptic vesicles and synaptic specializations, suggesting the synapses could be functional. Notably, however, we found that CTB-labeled regenerating dorsal column sensory axons emerging from the lesion site were either unmyelinated or poorly myelinated, in contrast with the intact state of these projections 46 . Demyelination of dorsal column sensory projections leads to conduction failure 23 . Although it is possible that remyelination might have occurred after the 6 week time point at which we assessed electrophysiological activity, a recent study reported a persistent loss of dorsal column sensory axon myelination in the thoracic spinal cord even 6 months after regeneration induced by antibody to NG2 and conditioning lesions 24 . Furthermore, spontaneous remyelination of injured host axons after SCI is reportedly unstable, falling over extended time periods post-lesion 47 . Persistent demyelination is therefore a candidate mechanism for the lack of synaptic activity observed here. Thus, despite the demonstration that conditioning of the injured neuron together with chemotropic guidance can direct regenerating central axons to form synaptic contacts with appropriate gracilar targets, synaptic activity was not restored.
To the best of our knowledge, this is the first direct observation of a concept that has been previously advanced, but not proven, that comprehensive attempts to restore functional neural circuitry after SCI must address not only axonal growth and target location, but also remyelination. It is not likely that regenerated axons will be functional unless action potentials can be efficiently transmitted through regenerated segments. Our study highlights the complexities of restoring function and provides a model system in which these complexities can be further explored.
In summary, we found a tropic dependency for target reinnervation and provide evidence for supraspinal target reinnervation after combinatorial application of therapies to the injured adult CNS. Progress in understanding mechanisms of appropriate axon guidance and termination is of critical importance in the field of CNS regeneration, as experimental strategies that enhance axonal growth after injury in the adult CNS continue to be identified. Axons face far more inappropriate than appropriate targets when extending beyond lesion sites after SCI, and the elucidation of mechanisms that guide directional growth into appropriate targets is essential. Our results identify chemotropic guidance as an important mechanism that can guide regenerating axons into appropriate targets and leads to synapse formation.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/natureneuroscience/.
Note: Supplementary information is available on the Nature Neuroscience website.
ONLINE METHODS
Production of lentiviral vectors and isolation of MSCs. NT-3 and control (GFP expressing) lentiviral plasmids were constructed as previously described 10 . The NT-3 virus construct contains a GFP expression cassette 48 . Vector titers were assayed by infection of 293 cells and quantification of p24 levels as previously described 10 . NT-3 vector preparations were diluted to 100 or 200 mg ml À1 p24 (8.3 Â 10 7 or 1.7 Â 10 8 infectious units ml À1 ) before injection. Rat primary MSCs were isolated from tibias and femurs, as previously described 49 . Briefly, tibias and femurs were dissected and bone marrow was extruded. Cells were cultured in alpha-MEM medium (Invitrogen) supplemented with 20% fetal bovine serum (FBS) and antibiotics.
Surgical procedures. We used adult female Fischer 344 rats weighing 150-200 g sed. Institutional Animal Care and Use Committee of the Veterans Administration Medical Center San Diego and US National Institutes of Health and Society for Neuroscience guidelines on animal care were followed. Rats were anesthetized with a combination (2 ml per kg of body weight) of ketamine (25 mg ml À1 ), xylazine (1.3 mg ml À1 ) and acepromazine (0.25 mg ml À1 ). Gracilar neurons were retrogradely labeled by injections of Fluorogold into the ventroposterolateral (VPL) nucleus of the thalamus 1 week before spinal cord lesion surgery (Fig. 1) Immediately following retrograde labeling, some rats received bilateral conditioning lesions, in which the sciatic nerve was crushed at mid-thigh level with a jeweler's forceps for 15 s. For C1 lesion and vector injections, rats were fixed in a spinal stereotaxic unit and a partial laminectomy was performed to remove the rostral half of the C1 vertebrae. Dorsal column lesions were made 1.5 mm caudal to the obex using a Kopf microwire device (Kopf Instruments). The wire knife was lowered 0.5 mm into the spinal cord at a position 1.25 mm to the left of the midline. Extrusion of the wire knife formed a 2.5-mm-wide arc that was raised to the dorsal surface of the cord, transecting the ascending (sensory) axon tracts.
Immediately following the lesion, 2 ml (75,000 cells ml À1 ) of MSCs was pressure injected (Picospritzer II, General Valve) through a small hole in the dura mater into the lesion space. Next, lentiviral vectors were pressure injected through pulled glass capillaries 1.75 mm rostral to the C1 lesion site into the rostral portion of the nucleus gracilis and reticular nucleus bilaterally (1.25 ml per side) or into the nucleus gracilis alone. Injections targeting the nucleus gracilis and reticular nucleus distributed vector primarily at depths spanning 0.25-0.5 mm and 1.0 mm below the dorsal brainstem surface, respectively. Rats received injections of 1% CTB (2 ml, wt/vol, List Biologicals) into the right and left sciatic nerves 4 weeks after injury/treatment surgery to label ascending sensory projections transganglionically. The rats were killed by perfusion 3 d later with either 4% paraformaldehyde (wt/vol, histology/immunocytochemistry) or 4% paraformaldehyde and 2.5% glutaraldehyde (vol/vol, electron microscopy).
Immunohistochemical analysis of brainstem sections. For immunohistochemical analysis, every sixth 35-mm-thick section was labeled for CTB using streptavidin-HRP light-level immunohistochemistry followed by GFP and GFAP fluorescent immunolabeling as described previously 10 . Goat antibody to CTB (1:80,000, List) was used to detect ascending sensory axons, monoclonal antibody to GFAP (1:1,000, Chemicon) was used to label astrocytes and rabbit antibody to GFP (1:750, Molecular Probes) was used to label vectortransduced cells as previously described 10 . For confocal analysis, double immunofluorescent labeling of CTB and Fluorogold was performed using a 3-d incubation at 4 1C with primary antibodies (rabbit antibody to fluorogold, 1:2,000, Chemicon; goat antibody to CTB, 1:20,000) followed by fluorescence-conjugated secondary antibody incubation. For double immunofluorescent labeling of CTB and MAG, sections were incubated for 3 d at 4 1C with primary antibodies (goat antibody to CTB, 1:10,000; mouse antibody to MAG, 1:250, Millipore) followed by incubation with fluorescentconjugated secondary antibodies. Brainstem sections were labeled for NT-3 using streptavidin-HRP light-level immunohistochemistry, as previously described 10 , with a 2-d primary antibody incubation at 4 1C (goat antibody to NT-3, Neuromics, GT15000, 1:1000).
Animal exclusion criteria. Lesions were considered to be potentially incomplete on the basis of highly conservative criteria; a rat was excluded if examination of every sixth 35-mm-thick section immunolabeled for GFAP indicated an incomplete interruption of GFAP-labeled astrocytes at the lesion site, in particular at the most dorsal aspect, or if tissue architecture anywhere in the lesion site resembled host tissue rather than grafted cells. On the basis of these criteria, we excluded rats in Lenti-NT-3+NoCL (n ¼ 3) and Lenti-NT-3+CL (n ¼ 1). Rat numbers stated in Results are the final numbers of rats included per group.
Quantification of axon profiles in the nucleus gracilis. Axon profiles in the nucleus gracilis were quantified using StereoInvestigator software (Microbrightfield). In a series of every sixth 35-mm-thick section, the three most medial sections were selected for analysis by an observer that was blind to group identity. For each section, the nucleus gracilis was outlined and overlayed with a point grid consisting of crosses (+) spaced 25 mm apart and placed at a randomized angle. Each grid point that was intersected by a CTB-labeled axon was counted. The number of grid points with intersections was then divided by the total number of grid points in the nucleus gracilis to determine percent axon intersections (grid points with axon intersections per total grid points). Percent axon intersections in three quantified sections per rat were compared between groups.
Electron microscopic analysis of brainstem sections. Two rats that received combined treatment with conditioning lesions and high-titer Lenti-NT-3 vector injection into the nucleus gracilis and three intact rats were used for electron microscopy, as described previously 50 . Briefly, after CTB/GFAP immunohistochemical labeling of one series of one in six sections to verify lesion completeness, adjacent sections were immunolabeled for CTB. Two to three of these sections per rat were prepared for electron microscopy analysis by osmication in 1% osmium tetroxide (wt/vol), dehydration, embedding in Durcopan ACM (Electron Microscopy Sciences) and sandwiching between Aclar embedding films. Ultrathin sections (60-70 nm) were serially collected on formvar-coated copper one-hole grids, counterstained with uranyl acetate and lead citrate, and fields were examined at a screening magnification of 4,800Â in a JEOL 100 CX electron microscope. Two to five ultrathin sections were examined per rat for evidence of CTB-labeled synaptic structures. Approximately 80 fields were examined in lesioned subjects and 40 fields in intact subjects.
Electrophysiology. Electrophysiological recordings were collected from the nucleus gracilis after sciatic nerve stimulation. Measurements were made in intact rats (n ¼ 3), rats with intact spinal cords but crushed (conditioned) sciatic nerves (n ¼ 3), rats with C1 dorsal column lesions, conditioning lesions, cell grafts and high-titer Lenti-NT-3 injections to the nucleus gracilis (Lenti-NT-3 high + CL, n ¼ 5), and rats with C1 dorsal column lesions, conditioning lesions, cell grafts and high-titer Lenti-GFP injections into the target (Lenti-GFP high + CL, n ¼ 3). Data were obtained 6 weeks after lesion/treatment from urethane-anesthetized rats (1.2-1.6 g per kg, intraperitoneal). Wire electrodes for stimulation were hooked around sciatic nerves bilaterally. Rats were then secured in a precision stereotax and glass microelectrodes (1-3 MO impedance) filled with 3M NaCl were used to obtain extracellular recordings from the ipsilateral nucleus gracilis. Recordings were made at regular intervals beginning 200 mm rostral through 1,400 mm caudal to the obex and 500 mm mediolateral of the midline and continued through a range of 100-500 mm below the dorsal surface of the brainstem. The sciatic nerve was stimulated at 20-s intervals using a current of 1.0 mA. The magnitude of nucleus gracilis unit responses were quantified over a 10-ms window, beginning 6.0 ms after the stimulus onset, by calculating the RMS of the waveform. Each post stimulus value was normalized by subtracting the RMS values calculated from a 10-ms window ending 6 ms before the stimulus onset. This method of analysis yielded a single numerical value for the response that was normalized to the prestimulus baseline gracilis activity at each recording site. For each recording site, several responses were recorded and the average RMS response was determined. The maximum RMS response observed in lesioned rats lacking regenerated axons (Lenti-GFP high +
